Cardinal Health (NYSE:CAH) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Cardinal Health (NYSE:CAH - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $1.95 by $0.13, Briefing.com reports. The company had revenue of $54.90 billion during the quarter, compared to analyst estimates of $56.05 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. During the same period in the previous year, the business earned $1.74 EPS. The firm's revenue for the quarter was up 8.7% on a year-over-year basis. Cardinal Health updated its FY24 guidance to $7.30-7.40 EPS and its FY25 guidance to at least $7.50 EPS.

Cardinal Health Stock Performance

NYSE:CAH traded down $4.08 during trading hours on Friday, reaching $98.90. The stock had a trading volume of 3,445,729 shares, compared to its average volume of 2,288,769. The stock has a market capitalization of $24.06 billion, a PE ratio of 38.94, a PEG ratio of 1.03 and a beta of 0.71. Cardinal Health has a 52 week low of $77.56 and a 52 week high of $116.04. The company has a 50 day moving average price of $109.28 and a two-hundred day moving average price of $104.97.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date was Thursday, March 28th. Cardinal Health's payout ratio is presently 78.74%.

Analyst Upgrades and Downgrades

Several research firms recently commented on CAH. Leerink Partnrs reissued an "outperform" rating on shares of Cardinal Health in a research report on Monday, February 26th. Wells Fargo & Company dropped their target price on shares of Cardinal Health from $96.00 to $94.00 and set an "underweight" rating on the stock in a report on Monday. UBS Group increased their price target on Cardinal Health from $122.00 to $125.00 and gave the company a "buy" rating in a report on Monday, February 5th. StockNews.com raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Thursday. Finally, Robert W. Baird reduced their price objective on Cardinal Health from $134.00 to $128.00 and set an "outperform" rating for the company in a research report on Friday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $105.79.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.